A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML

Wenxin Du¹, Zhimei Xia¹, Zebin Luo², Yichang Chen³, Shaowei Bing¹, Wei Wang¹, Xingya Zhang¹, Zhan Zhou³, Jingying Zhang², Ji Cao^{1

4}, Bo Yang^{1

4}, Qiaojun He^{1

4

5}, Xuejing Shao⁶, Xiaojun Xu⁷, Meidan Ying^{8

9

10

11}

Affiliations

¹ Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China.
² Division of Hematology-Oncology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 310052, Hangzhou, China.
³ Innovation Institute for Artificial Intelligence in Medicine, Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences and Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare, Zhejiang University, 310018, Hangzhou, China.
⁴ Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, 310000, Hangzhou, China.
⁵ Cancer Center, Zhejiang University, 310058, Hangzhou, China.
⁶ Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China. xjshao@zju.edu.cn.
⁷ Division of Hematology-Oncology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 310052, Hangzhou, China. xuxiaojun@zju.edu.cn.
⁸ Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China. mying@zju.edu.cn.
⁹ Division of Hematology-Oncology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 310052, Hangzhou, China. mying@zju.edu.cn.
¹⁰ Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, 310000, Hangzhou, China. mying@zju.edu.cn.
¹¹ Cancer Center, Zhejiang University, 310058, Hangzhou, China. mying@zju.edu.cn.

PMID: 37714925
DOI: 10.1038/s41375-023-02024-6

Case Reports

A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML

Wenxin Du et al. Leukemia. 2023 Nov.

. 2023 Nov;37(11):2286-2291.

doi: 10.1038/s41375-023-02024-6. Epub 2023 Sep 15.

Authors

Affiliations

¹ Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China.
² Division of Hematology-Oncology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 310052, Hangzhou, China.
³ Innovation Institute for Artificial Intelligence in Medicine, Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences and Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare, Zhejiang University, 310018, Hangzhou, China.
⁴ Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, 310000, Hangzhou, China.
⁵ Cancer Center, Zhejiang University, 310058, Hangzhou, China.
⁶ Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China. xjshao@zju.edu.cn.
⁷ Division of Hematology-Oncology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 310052, Hangzhou, China. xuxiaojun@zju.edu.cn.
⁸ Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China. mying@zju.edu.cn.
⁹ Division of Hematology-Oncology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 310052, Hangzhou, China. mying@zju.edu.cn.
¹⁰ Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, 310000, Hangzhou, China. mying@zju.edu.cn.
¹¹ Cancer Center, Zhejiang University, 310058, Hangzhou, China. mying@zju.edu.cn.

PMID: 37714925
DOI: 10.1038/s41375-023-02024-6

No abstract available

PubMed Disclaimer

References

1. Hollink IHIM, van den Heuvel-Eibrink MM, Arentsen-Peters STCJM, Pratcorona M, Abbas S, Kuipers JE, et al. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood. 2011;118:3645–56. - DOI - PubMed
1. Bisio V, Zampini M, Tregnago C, Manara E, Salsi V, Di Meglio A, et al. NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group. Leukemia 2017;31:974–7. - DOI - PubMed
1. Struski S, Lagarde S, Bories P, Puiseux C, Prade N, Cuccuini W, et al. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis. Leukemia 2017;31:565–72. - DOI - PubMed
1. Huber S, Baer C, Hutter S, Dicker F, Meggendorfer M, Pohlkamp C, et al. AML classification in the year 2023: How to avoid a Babylonian confusion of languages. Leukemia 2023;37:1413–20. - DOI - PubMed - PMC
1. Chen X, Wang F, Zhang Y, Ma XL, Cao PX, Yuan LL, et al. Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center. Blood Cancer J. 2021;11:112. - DOI - PubMed - PMC

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

82273942/National Natural Science Foundation of China (National Science Foundation of China)

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML

Affiliations

A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML

Authors

Affiliations

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical